Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引：5

作者：

Gulpen, Anouk J. W. ^{[1
,2
,3
]}

Braeken, Dionne C. W. ^{[1
]}

Schalla, Simon ^{[2
,4
]}

Ten Cate, Hugo ^{[1
,2
,3
]}

Crijns, Harry J. ^{[2
,4
]}

Ten Cate-Hoek, Arina J. ^{[1
,2
]}

机构：

[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands

[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands

[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands

[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands

来源：

ACTA HAEMATOLOGICA | 2022年 / 145卷 / 05期

关键词：

Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;

D O I：

10.1159/000524094

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel

引用

页码：476 / 483

页数：8

共 31 条

[1] Oral Apixaban for the Treatment of Acute Venous Thromboembolism [J].

Agnelli, Giancarlo ;

Buller, Harry R. ;

Cohen, Alexander ;

Curto, Madelyn ;

Gallus, Alexander S. ;

Johnson, Margot ;

Masiukiewicz, Urszula ;

Pak, Raphael ;

Thompson, John ;

Raskob, Gary E. ;

Weitz, Jeffrey I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :799-808

[2] Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study [J].

Banerjee, Amitava ;

Benedetto, Valerio ;

Gichuru, Philip ;

Burnell, Jane ;

Antoniou, Sotiris ;

Schilling, Richard J. ;

Strain, William David ;

Ryan, Ronan ;

Watkins, Caroline ;

Marshall, Tom ;

Sutton, Chris J. .

HEART, 2020, 106 (02) :119-+

[3] Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the Necessity-Concerns Frarnework [J].

Clifford, Sarah ;

Barber, Nick ;

Horne, Rob .

JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 64 (01) :41-46

[4] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[5] ESPACOMP Medication Adherence Reporting Guideline (EMERGE) [J].

De Geest, Sabina ;

Zullig, Leah L. ;

Dunbar-Jacob, Jacqueline ;

Helmy, Remon ;

Hughes, Dyfrig A. ;

Wilson, Ira B. ;

Vrijens, Bernard .

ANNALS OF INTERNAL MEDICINE, 2018, 169 (01) :30-+

[6] Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].

Giugliano, Robert P. ;

Ruff, Christian T. ;

Braunwald, Eugene ;

Murphy, Sabina A. ;

Wiviott, Stephen D. ;

Halperin, Jonathan L. ;

Waldo, Albert L. ;

Ezekowitz, Michael D. ;

Weitz, Jeffrey I. ;

Spinar, Jindrich ;

Ruzyllo, Witold ;

Ruda, Mikhail ;

Koretsune, Yukihiro ;

Betcher, Joshua ;

Shi, Minggao ;

Grip, Laura T. ;

Patel, Shirali P. ;

Patel, Indravadan ;

Hanyok, James J. ;

Mercuri, Michele ;

Vogelmann, O. ;

Gonzalez, C. ;

Ahuad Guerrero, R. ;

Rodriguez, M. ;

Albisu, J. ;

Rosales, E. ;

Allall, O. ;

Reguero, M. ;

Alvarez, C. ;

Garcia, M. ;

Ameriso, S. ;

Ameriso, P. ;

Amuchastegui, M. ;

Caceres, M. ;

Beloscar, J. ;

Petrucci, J. ;

Berli, M. ;

Budassi, N. ;

Valle, M. ;

Bustamante Labarta, G. ;

Saravia, M. ;

Caccavo, A. ;

Fracaro, V. ;

Cartasegna, L. ;

Novas, V. ;

Caruso, O. ;

Saa Zarandon, R. ;

Colombo, H. ;

Morandini, M. ;

Cuello, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104

[7] Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].

Granger, Christopher B. ;

Alexander, John H. ;

McMurray, John J. V. ;

Lopes, Renato D. ;

Hylek, Elaine M. ;

Hanna, Michael ;

Al-Khalidi, Hussein R. ;

Ansell, Jack ;

Atar, Dan ;

Avezum, Alvaro ;

Cecilia Bahit, M. ;

Diaz, Rafael ;

Easton, J. Donald ;

Ezekowitz, Justin A. ;

Flaker, Greg ;

Garcia, David ;

Geraldes, Margarida ;

Gersh, Bernard J. ;

Golitsyn, Sergey ;

Goto, Shinya ;

Hermosillo, Antonio G. ;

Hohnloser, Stefan H. ;

Horowitz, John ;

Mohan, Puneet ;

Jansky, Petr ;

Lewis, Basil S. ;

Luis Lopez-Sendon, Jose ;

Pais, Prem ;

Parkhomenko, Alexander ;

Verheugt, Freek W. A. ;

Zhu, Jun ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992

[8] Organisation of care for patients using direct oral anticoagulants [J].

Gulpen, A. J. W. ;

van Dijk, J. K. ;

Damen, N. L. ;

ten Cate, H. ;

Schalla, S. ;

Ten Cate-Hoek, A. J. .

NETHERLANDS HEART JOURNAL, 2020, 28 (09) :452-456

[9] The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study [J].

Gulpen, Anouk J. W. ;

ten Cate, Hugo ;

Henskens, Yvonne M. C. ;

van Oerle, Rene ;

Wetzels, Rick ;

Schalla, Simon ;

Crijns, Harry J. ;

ten Cate-Hoek, Arina J. .

PLOS ONE, 2019, 14 (06)

[10] On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation [J].

Hermans, Astrid N. L. ;

van der Velden, Rachel M. J. ;

Gawalko, Monika ;

Verhaert, Dominique V. M. ;

Desteghe, Lien ;

Duncker, David ;

Manninger, Martin ;

Heidbuchel, Hein ;

Pisters, Ron ;

Hemels, Martin ;

Pison, Laurent ;

Sohaib, Afzal ;

Sultan, Arian ;

Steven, Daniel ;

Wijtvliet, Petra ;

Tieleman, Robert ;

Gupta, Dhiraj ;

Dobrev, Dobromir ;

Svennberg, Emma ;

Crijns, Harry J. G. M. ;

Pluymaekers, Nikki A. H. A. ;

Hendriks, Jeroen M. ;

Linz, Dominik .

CLINICAL CARDIOLOGY, 2020, 43 (11) :1232-1239

← 1 2 3 4 →